| Symbol | TCBWF |
|---|---|
| Name | TC BIOPHARM (HOLDINGS) PLC |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | ML1 4WR United Kingdom SCL Maxim 1, 2 Parklands Way Maxim Park Eurocentral |
| Telephone | 44 (0) 141 433 7557 |
| Fax | — |
| — | |
| Website | https://tcbiopharm.com/ |
| Incorporation | GB |
| Incorporated On | 2020 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC;Pink Limited;NASDAQ |
| Auditor | Marcum LLP; |
| Audit Status | AUDITED |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0001872812 |
| Description | Clinical stage biopharmaceutical company engaged in the development of immunotherapy products based on a proprietary allogeneic gamma delta T cell platform Additional info from OTC: Additional info from Pink Limited: |
No news found.